Sarepta Therapeutics’ stock falls after patient dies of liver failure

10 months ago 44
ARTICLE AD BOX
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta Therapeutics’ stock falls after patient dies of liver failure

Related

Dollar tumbles to a four-year low as Trump claims it’s ‘doing great’

Dollar tumbles to a four-year low as Trump claims it’s ‘doin...

1 hour ago 0
These home buyers are suing one of the biggest mortgage lenders in America. Why you should pay attention.

These home buyers are suing one of the biggest mortgage lend...

1 hour ago 0
Investors aren’t scared of record gold and silver prices. Wall Street’s price targets are struggling to keep up.

Investors aren’t scared of record gold and silver prices. Wa...

4 hours ago 1

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

10 months ago 500
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

11 months ago 459
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 439
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 393
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 348
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved